Implantierbare Knochenleitungs- und aktive Mittelohrhörsysteme

ZUSAMMENFASSUNG

Bei audiologischen und/oder anatomischen Limitationen in der Versorgung mit konventionellen Hörgeräten können moderne teil- oder vollimplantierbare Hörsysteme in ausgewählten Fällen die Versorgungsmöglichkeiten komplettieren. Es konnte gezeigt werden, dass sich für eine Vielzahl an Patienten Verbesserungen im Tragekomfort, im Sprachverständnis und somit der Lebensqualität erzielen lassen.

Abstract

In case of audiological and/or anatomical limitations in the provision of conventional hearing aids, semi- or fully-implantable hearing systems represent a modern therapy alternative. These hearing systems are divided according to their mode of action into active middle ear implants when stimulating the auditory ossicles or the round window, into bone conduction devices while stimulating the skull directly, into cochlear implants with direct acoustic stimulation to the cochlea with its auditory nerve and finally into auditory brainstem implants by bridging the peripheral auditory structures. Taking careful criteria of indications and anatomical specificities into account, significant improvements can be achieved in comfort, speech understanding and thus quality of life for a large number of patients.

Schlüsselwörter

Implantierbare Hörsysteme - Knochenleitungshörsysteme (KLHS) - aktive Mittelohrhörsysteme (AMHS) - Schwerhörigkeit

Key words

implantable ear devices - bone conduction ear devices - active middle ear devices - hearing loss

• Literatur

• 1 Hesse G. Hörgeräte im Alter. HNO 2004; 52: 321-328
• 2 Zahnert T. Schwerhörigkeit – Ätiologie, Diagnostik und auditive Rehabilitation. Laryngo-Rhino-Otol 2010; 89: 669-693
• 3 Gates GA, Mills JH. Presbyacusis. Lancet 2005; 366: 1111-1120
• 4 Strawbridge WJ, Wallhagen MI, Shema SJ, Kaplan GA. Negative consequences of hearing impairment in old age. A longitudinal analysis. Gerontologist 2000; 40: 320-326
• 5 Volkenstein S, Thomas JP, Dazert S. Implantierbare Knochenleitungs- und aktive Mittelohrhörsysteme. Laryngo-Rhino-Otol 2016; 95: 352-363
• 6 Strutz J, Mann W. Implantierbare Hörgeräte. Praxis der HNO-Heilkunde, Kopf- und Halschirurgie 2009; 2: 972
• 7 Nelissen RC, Stalfors J, de Wolf MJ et al. Long-term stability, survival, and tolerability of a novel osseointegrated implant for bone conduction hearing: 3-year data from a multicenter, randomized, controlled, clinical investigation. Otol Neurotol 2014; 35: 1486-1491
• 8 Bosman A, Snik AF, Hol MK, Mylanus EA. Evaluation of a new powerful bone-anchored hearing system: a comparison study. J Am Acad Audiol 2013; 24: 505-513
• 9 Badran K, Arya AK, Bunstone D, Mackinnon N. Long-Term complications of bone-anchored hearing aids: a 14 years experience. J Laryngol Otol 2009; 123: 170-176
• 10 Dun CA, Faber HT, de Wolf MJ et al. Assessment of more than 1000 implanted percutaneous bone conduction devices: skin reactions and implant survival. Otol Neurotol 2012; 33: 192-198
• 11 Wazen JJ, Wycherly B, Daugherty J. Complications of Bone-Anchored Hearing Devices. Adv Otorhinolaryngol 2011; 71: 63-72
• 12 Reinfeldt S, Håkansson B, Taghavi H, Eeg-Olofsson M. New developments in bone conduction hearing implants: A review. Med Devices (Auckl) 2015; 8: 79-93
• 13 Shin JW, Kim SH, Choi JY et al. Surgical and Audiologic Comparison Between Sophono and Bone-Anchored Hearing Aids Implantation. Clin Exp Otorhinolaryngol 2016; 9: 21-26
• 14 Siegert R, Kanderske JA. New semi-implantable transcutaneous bone conduction device: clinical, surgical, and audiologic outcomes in patients with congenital ear canal atresia. Otol Neurotol 2013; 34: 927-934
• 15 Hunter JB, Carlson ML, Glasscock 3rd ME. The ototronix MAXUM middle ear implant for severe high-frequency sensorineural hearing loss: Preliminary results. Laryngoscope 2016; 126: 2124-2127
• 16 Colletti V, Soli SD, Carner M, Colletti L. Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol 2006; 45: 600-608
• 17 Busch S, Kruck S, Spickers D et al. First clinical experiences with a direct acoustic cochlear stimulator in comparison to preoperative fitted conventional hearing aids. Otol Neurotol 2013; 34: 1711-1718
• 18 Grossöhmichen M, Salcher R, Kreipe HH et al. The codacs^TM direct acoustic cochlear implant actuator: exploring alternative stimulation sites and their stimulation efficiency. PLoS ONE 2015; 10: e0119601
• 19 Lenarz T, Schwab B, Maier H, Kludt E. Direct acoustic cochlear stimulation for therapy of severe to profound mixed hearing loss: CodacsTM Direct Acoustic Cochlear Implant System. HNO 2014; 62: 481-489
• 20 Jenkins HA, Uhler K. Otologics active middle ear implants. Otolaryngol Clin N Am 2014; 47: 967-978
• 21 Pelosi S, Carlson M, Glasscock ME. The Ototronix MAXUM system: Indications, techniques, and outcomes. Otolaryngol Head Neck Surg 2014; 25: 338-343
• 22 Braun K, Zenner HP, Friese N, Tropitzsch A. Differenzialindikation aktiver Mittelohrimplantate. HNO 2015; 6: 401-418
• 23 Debeaupte M, Decullier E, Tringali S et al. Evolution of the reliability of the fully implantable middle ear transducer over successive generations. Otol Neurotol 2015; 36: 625-630
• 24 Kraus EM, Shohet JA, Catalano PJ. Envoy Esteem Totally Implantable Hearing System: phase 2 trial, 1-year hearing results. Otolaryngol Head Neck Surg 2011; 145: 100-109
• 25 Ihler F, Bewarder J, Blum J et al. Long Term functional outcome and satisfaction of patients with an active middle ear implant (...). Eur Arch Otorhinolaryngology 2014; 271: 3161-3169
• 26 Pulcherio JO, Bittencourt AG, Burke PR et al. Carina^® and Esteem^®: a systematic review of fully implantable hearing devices. PLoS One 2014; 9: e110636